{"pub": "marketwatch", "url": "https://marketwatch.com/articles/cannabis-stocks-are-down-making-mergers-less-certain-51571909401", "downloaded_at": "2019-10-24 09:52:06.533798+00:00", "title": "Cannabis Stocks Are Down, Making Mergers Less Certain", "language": "en", "text": "Cannabis mergers have run aground since the tide went out on pot stocks. Earlier this month, MedMen Enterprises killed its $680 million deal with PharmaCann. A Tuesday press release by Cresco Labs proclaimed the completion of antitrust review for its $800 million merger with Origin House. But it went on to say the companies need to negotiate the terms of the deal they\u2019d announced in April, when cannabis stocks were at their peak.\n\nThe April deal had arranged for the exchange of 0.8428 of a Cresco share for each share of Origin...", "description": "The Cresco Labs $800 million deal with Origin House is headed for further negotiations even though it was announced in April.", "authors": ["Bill Alpert"], "top_image": "https://asset.barrons.com/public/resources/images/ON-DH108_Cresco_OR_20191023104646.jpg", "published_at": "2019-10-24"}